Pharmaceutical Technology

MAY 18, 2023

The European Medicines Agency (EMA) has published recommendations to increase communication and planning efforts in a bid stop the current medicine shortages becoming even worse. The EMA set up a task force in 2016 in light of issues concerning medicine availability and supply chain.

Medicine 99

Medicine Patients Pharmaceutical Healthcare 99

Fierce Pharma

FEBRUARY 7, 2023

Orexo, leveraging drug delivery tech, seeks FDA approval of nasal high-dose opioid rescue medicine ntaylor Tue, 02/07/2023 - 08:18

FDA 216

FDA Medicine 216

Pharmaceutical Technology

APRIL 24, 2023

Traditional medicine refers to the knowledge, skills and practices that indigenous and different cultures use to maintain health, encompassing forms such as herbal medicine, Traditional Chinese Medicine (TCM) and acupuncture. Studying the behaviour of animals can aid in drug discovery research too.

Medicine 105

Medicine Pharmaceutical Healthcare Healthcare 105

MedCity News

SEPTEMBER 28, 2023

We also hear from Chris Allen, who recently became CFO at Keck Medicine of USC. For the September episode, we discuss some recent executive appointments occurring in the healthcare sector, as well as layoffs affecting the industry.

Medicine 79

Medicine Healthcare Healthcare 79

Fierce Pharma

NOVEMBER 14, 2022

AstraZeneca and Sanofi win big as Europe's human medicines committee endorses approvals, label expansions. fkansteiner. Mon, 11/14/2022 - 08:59.

Medicine 206

Medicine 206

MedCity News

SEPTEMBER 20, 2023

The art of processing and producing valuable data, empowers researchers to identify potential drug targets, predict drug interactions, and optimize clinical trial designs, reducing time and costs associated with research endeavors and ultimately bringing the best quality medicines to meet our needs at a faster pace.

Pharmaceutical 96

Pharmaceutical Medicine Ethics Pharmaceutical research 96

European Pharmaceutical Review

MAY 18, 2023

A new document published by European Medicines Agency (EMA) makes ten recommendations and outlines good practices “to ensure continuity in the supply of human medicines, prevent shortages and reduce their impact.” Medicine shortages are a global health problem and are increasingly affecting European countries, according to EMA.

Medicine 88

Medicine Pharmaceutical Manufacturing Patients 88

European Pharmaceutical Review

FEBRUARY 21, 2023

The UK medicinal cannabis sector has witnessed important regulatory advances in recent years. In this Q&A, EPR caught up with CEO James Short and Managing Director Arthur Wakeley from Celadon, to learn more about the company’s experience moving through, and progressing, the strict regulatory process for medicinal cannabis.

Medicine 128

Medicine Manufacturing Pharmaceutical Patients 128

pharmaphorum

JANUARY 20, 2023

Leela Barham argues that the latest operational guidance for the NHS in England continues to illustrate a disconnect between the messages in big-ticket policy documents from the central government and the messages from the NHS in England on medicines. For that, the government has set out the Life Sciences Vision , published back in July 2021.

Medicine 105

Medicine Patients Government Pharmaceutical 105

European Pharmaceutical Review

FEBRUARY 2, 2023

While maintaining a healthy manufacturing industry for production of ‘high tech’ pharmaceuticals, Europe has stepped away from manufacturing essential medicines and active pharmaceutical ingredients (APIs) due to unrelenting price pressures and is now heavily reliant on the import of these critical ingredients.

Medicine 98

Medicine Manufacturing Pharmaceutical Patients 98

European Pharmaceutical Review

APRIL 13, 2023

6 Therefore, the quality of data provided to regulators will be key in obtaining MAs and subsequently marketing of psychedelic medicines. 6 Therefore, the quality of data provided to regulators will be key in obtaining MAs and subsequently marketing of psychedelic medicines. The Sydney Morning Herald. cited 2023Mar].

Medicine 113

Medicine Food and Drug Administration Pharmaceutical Doctors 113

Pharmatutor

JULY 4, 2023

Reality Test of Medicine Shop without Registered Pharmacist admin Tue, 07/04/2023 - 15:39 ABOUT AUTHOR Dr. R. Thakur Renowned Professor of Pharmaceutical Fraternity & Former Member of Pharmacy Council of India. Email : drramsthakur@gmail.com

Medicine 98

Medicine Pharmaceutical 98

Pharmaceutical Technology

MARCH 27, 2023

Regenerative medicines in early-stage development (preclinical, discovery, or investigational new drug [IND]/ clinical trial application [CTA] filed status) have seen a change in drug targets compared to therapies in late-stage development (Phase II to pre-registration stage).

Medicine 98

Medicine Marketing Leads 98

European Pharmaceutical Review

JULY 27, 2023

This decision by the European Commission (EC) follows the positive opinion of the Committee for Medicinal Products for Human Use (CHMP). The medicine works by inhibiting the C5 protein in the terminal complement cascade within the body. Soliris is administered intravenously every two weeks.

Medicine 80

Medicine Pharmaceutical Patients Safety 80

MedCity News

JULY 28, 2023

The food as medicine movement is gaining momentum, but there are several challenges, according to a PitchBook report. These challenges include resistance to diet restrictions and difficulty in tracking compliance.

Medicine 85

Medicine Food Medical 85

PM360

JUNE 26, 2023

Access to medicines have persisting and systemic differences across the globe and within countries. It is estimated that nearly two billion people globally do not have access to essential medicines. Traditionally, pharmaceutical companies have not prioritized emerging markets as part of their access strategy.

Medicine 98

Medicine Pharma Pharmaceutical Marketing 98

European Pharmaceutical Review

FEBRUARY 13, 2023

Tokyo researchers have developed a new analytical platform based on liquid chromatography, mass spectrometry and software analysis that quantifies the structure of messenger RNA (mRNA)-based medicines. It promises unparalleled efficiency in checking for the quality of mRNA medicines, both those in action now and yet to be developed.

Medicine 100

Medicine Pharmaceutical Manufacturing 100

European Pharmaceutical Review

NOVEMBER 10, 2022

A new wave of medicines has emerged in recent years to supplement the well-established small and large molecule platforms that have historically dominated the market. Complex medicines offer diverse therapeutic modalities, including RNA therapeutics and antibody-drug conjugates (ADCs). What constitutes a complex medicine?

Medicine 95

Medicine Pharmaceutical Patients Distribution 95

European Pharmaceutical Review

MAY 26, 2023

The Medicines and Healthcare products Regulatory Agency ( MHRA ) has announced that new international regulatory recognition routes for medicines will be established using approvals from the EU, Switzerland, US, Canada, Australia, Singapore and Japan.

Medicine 83

Medicine Patients Pharmaceutical Healthcare 83

European Pharmaceutical Review

JULY 5, 2023

European Commission (EC) has granted approval for the label extension of cystic fibrosis medicine ORKAMBI ® (lumacaftor/ivacaftor) for children aged one to <2 years old. How does the oral cystic fibrosis medicine work? In these patients, the CFTR protein is not processed and trafficked normally within the cell.

Medicine 72

Medicine Pharmaceutical Patients Medical 72

Pharmaceutical Technology

JANUARY 16, 2023

CARsgen Therapeutics has announced a col labor ation with Huadong Medicine to commercialise zevorcabtagene autoleucel (zevor-cel), CT053, in mainland China. Under the collaboration, Huadong Medicine will have the exclusive right to commercialise CARsgen’s CT053 in mainland China.

Medicine 119

Medicine Food and Drug Administration Pharmaceutical FDA 119

Pharmaceutical Technology

MAY 23, 2023

The US Food and Drug Administration (FDA) has granted approval for Blueprint Medicines’ Ayvakit (avapritinib) as the first and only treatment for indolent systemic mastocytosis (ISM) in adult patients. The precision therapy has been designed for potently and selectively inhibiting KIT D816V, which is the main underlying driver of the disease.

FDA 98

FDA Medicine Food and Drug Administration Patients 98

pharmaphorum

JANUARY 24, 2023

Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition. Medicines and medical technology manufacturing delivered annual exports worth over £30 billion ($37 billion) for the UK in 2019, on top of making a £32.1 It’s not all bad news.

Medicine 111

Medicine Manufacturing Pharmaceutical manufacturing Pharmaceutical 111

pharmaphorum

JANUARY 17, 2023

Late last year, pharmaphorum spoke with AstraZeneca’s Ben Challis, VP and head of translational science and experimental medicine, cardiovascular, renal, and metabolism (CVRM), together with Magnus Jörnten-Karlsson, executive director of Unify. The post Driving clinical trial innovation forward with precision medicine appeared first on.

Medicine 98

Medicine Patients Healthcare Healthcare 98

European Pharmaceutical Review

MARCH 14, 2023

Parallel import of medicinal products is one of the basic and admissible forms of international trade in the European Union (EU) market, based on the principle of free movement of goods established by the Treaty on the Functioning of the European Union.

Medicine 81

Medicine Pharmaceutical Pharma Marketing 81

MedCity News

MAY 30, 2023

Employers have a responsibility to support the food as medicine movement and help employees who are food insecure, said Jay Bhatt, managing director of Deloitte Services and managing director of the Center for Health Solutions and Health Equity Institute. He made these comments last week at the MedCity INVEST conference in Chicago.

Medicine 101

Medicine Food Management 101

European Pharmaceutical Review

MARCH 31, 2023

The Medicines Patent Pool (MPP) has signed sublicence agreements with three generics manufacturers to produce generic versions of cabotegravir long-acting (LA) injectable for human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP). The pharma companies who will manufacture the generic versions are Viatris, Aurobindo and Cipla.

Medicine 102

Medicine Manufacturing Food and Drug Administration Pharma 102

pharmaphorum

OCTOBER 28, 2022

In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organisations continue to prioritise the UK as a launch destination. Angela McFarlane ?,

Medicine 122

Medicine Pharmaceutical Patients Healthcare 122

MedCity News

MAY 10, 2023

Medical Affairs plays a critical role when it comes to driving adherence to evidence-based medicine (EBM) – the principle that clinical decisions should be informed by the best available scientific evidence, along with clinical experience and patient preference.

Medicine 107

Medicine Medical Patients Biopharma 107

pharmaphorum

OCTOBER 12, 2022

Genomic medicine is a rapidly growing space in which researchers use the information in a person’s genes to identify and administer medical treatment.”. The evolving field of genomic medicine. There are two components to genomic medicine, known as the payload and the vector. Forging an AI-enabled path toward precision medicine.

Medicine 105

Medicine Patients Pharmaceutical Healthcare 105

European Pharmaceutical Review

AUGUST 7, 2023

The US Food and Drug Administration ( FDA ) has approved Zurzuvae ( zuranolone ), the first oral medicine to treat postpartum depression (PPD) in adults. The post First oral medicine for postpartum depression approved appeared first on European Pharmaceutical Review.

Medicine 72

Medicine Food and Drug Administration FDA Patients 72

European Pharmaceutical Review

JANUARY 25, 2023

The European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for exagamglogene autotemcel (exa-cel), the first regulatory submission for a CRISPR-based medicine. The MAA from Vertex Pharmaceuticals and CRISPR Therapeutics is supported by two global Phase III studies.

Medicine 101

Medicine Food and Drug Administration Pharmaceutical FDA 101

European Pharmaceutical Review

JUNE 14, 2023

To be a superpower globally, the UK life sciences sector must not only discover and develop medicines of the future domestically, but also manufacture a significant share in the country too, according to a new report from the Medicines Manufacturing Industry Partnership (MMIP). It provides almost 45 percent of the £36.9

Medicine 52

Medicine Manufacturing Pharmaceutical Government 52

MedCity News

MAY 18, 2023

Malla, a startup that launched Wednesday, is trying to make functional, personalized medicine more accessible. Consumers can purchase a membership, which includes one-on-one video sessions with a practitioner, messaging, personalized care plans and tracking.

Medicine 73

Medicine 73

European Pharmaceutical Review

NOVEMBER 23, 2022

The European Medicines Agency (EMA) has established the Quality Innovation Expert Group (QIG) to aid innovative approaches for the development, manufacture and quality control (QC) of medicines, including new technologies, digitalisation, novel materials and novel devices for patients in the European Union (EU).

Medicine 97

Medicine Pharmaceutical Manufacturing Patients 97

European Pharmaceutical Review

JANUARY 31, 2023

A new strategy for 2023-2025 by the Medicines Patent Pool (MPP) aims to reduce access inequities, by improving the availability and affordability of health products in low- and middle-income countries (LMICs). The organisation’s work on essential medicine access is also funded by the Swiss Agency for Development and Cooperation (SDC).

Medicine 87

Medicine Manufacturing Pharmaceutical Healthcare 87

European Pharmaceutical Review

JULY 3, 2023

Positively, regarding the drug’s development , Mayer added that Ipsen plans “to move forward with regulatory submissions to the US Food and Drug Administration and the European Medicines Agency [EMA].” The post Could small molecule medicine treat rare liver disease? appeared first on European Pharmaceutical Review.

Medicine 84

Medicine Food and Drug Administration Patients Pharmaceutical 84